Important Announcement Tender for Technical and Lab Equipment

Department of Hemostasis and Thrombosis


Name - Dr. Rucha Kiran Patil

Degree - M.Sc, Ph.D

Designation - Scientist B

Email - ruchakpatil286@gmail.com

Degree University Subject Year
B.Sc Mumbai University Biotechnology Along with Chemistry, Zoology, Drugs and Dyes 2007
M.Sc Mumbai University Biotechnology 2009
Ph.D Mumbai University Applied Biology 2015
Post Doctoral Fellowship ICMR Dengue Fever and cell-derived microparticles 2016 - 2017
  • INSA Young Scientist Award 2017 in the year 2017 by Indian National Science Academy in the category of Health Science on the topic of "Cell-derived Microparticles(MPs) and their role in different clinical settings"
  • ICMR Post Doctoral Fellowship award in the year 2016 for the project entitled “Assessing the role of cell-derived microparticles in Dengue virus infection”
  • Best Poster Prize (Consolation) in the year 2016 at the Best of European Hematology Association (EHA) Conference organized by Mumbai hematology group for the study entitled “Mortality and causes of death in patients with hemophilia and von Willebrand disease during the period 2002-2015 (14 years) from Mumbai: a prospective cohort study”.
  • Best Poster Prize (Laboratory) in the year 2015 at International Haematology Society of Australia and New Zealand, the Australian & New Zealand Society of Blood Transfusion and the Australasian Society of Thrombosis and Haemostasis (HAA) 2015 for the study entitled “A simple clot based assay for detection of procoagulant cell-derived Microparticles”
  • Best Poster Award in the year 2014 at National conference of Indian Society of Hematology and Blood Transfusion 2014 held at Ramoji Film City, Hyderabad for the paper entitled “Microparticles as potential biomarkers for anticoagulant therapy in women with pregnancy loss”
  • Dr. H.M. Bhatia Oral Presentation Award in the year 2014 at 37th Annual Conference of Mumbai Hematology Group held at Tata Memorial Centre, ACTREC for the paper entitled “Risk Assessment of Thrombophilia Markers, New and Old, and Anticoagulation Therapy in Recurrent Pregnancy Loss”
  • Dr. J.C. Patel Award for Oral Presentation in the year 2013 at Mumbai Haematology Group Annual Conference for the paper entitled “Elevated procoagulant microparticles in women with recurrent pregnancy loss”
  • CSIR/NET-Junior research fellowship in the year 2010
  • Patil R, Ghosh K, Shetty S. Mortality analysis in severe and non-severe hemophilia patients- a crucial requirement in developing countries. J Thromb Haemost.2017 [Recently accepted] [Impact factor: 5.56].
  • Patil R, Ghosh K, S Chandrakala, Shetty S. A possible need for routine screening for Strongyloides stercoralis infection in Indian haemophilia patients. Indian J Med Res. 2017 [Recently accepted] [Impact factor: 2.061].
  • Patil R, Mukaddam A, Ghosh K, Shetty S. Management of pregnancy in dysfibrinogenemia cases- a dilemma. Blood Coagul Fibrinolysis. 2017 Jan;28(1):91-93. [Impact factor: 1.403]
  • Patil R, Ghosh K, Shetty S. Microparticles as a biomarker for monitoring extended-duration Betrixaban. N Engl J Med. 2016 Dec 15;375(24):e50. [Impact factor: 59.55].
  • Patil R, Ghosh K, Shetty S. Comment on Salomon et al. Gestational diabetes mellitus Is associated with changes in the concentration and bioactivity of placenta-derived exosomes in maternal circulation across gestation. Diabetes. 2016 Jul;65(7):e24-5. [Impact factor: 8.474].
  • Patil R, Ghosh K, Shetty S. Could procoagulant cell-derived microparticles have a more crucial role in pregnancy complications rather than exosomes? Am J Obstet Gynecol. 2016 Jun;214(6):765-6. [Impact factor: 4.704]
  • Patil R, Ghosh K, Mukherjee S, Shetty S. Does consumption of platelet-derived microparticles in the fibrin clot explain the decrease in their percentage during pregnancy? Blood Cells Mol. Diseases 2016 Mar;57:115-7. [Impact factor: 2.646].
  • Patil R, Ghosh K, Shetty S. Decrease in circulating percentageplatelet microparticles duringpregnancy—a different perspective. Ann Hematol. 2016 Feb;95(3):533-4. [Impact factor: 2.63]
  • Patil R, Ghosh K, Shetty S. Annexin A5 levels or circulating microparticles: What we see depends mainly on what we look for. J Intern Med. 2016 Jun;279(6):608. [Impact factor: 6.06]
  • Patil R, Ghosh K, Shetty S. A simple clot based assay for detection of procoagulant cell-derived Microparticles. Clin Chem Lab Med. 2016 May;54(5):799-803. [Impact factor: 2.7]
  • Patil R, Ghosh K, Shetty S. Comment: Does low-molecular-weight heparin influence fetal growth or uterine and umbilical arterial Doppler in women with a history of early-onset uteroplacental insufficiency and an inheritable thrombophilia? Secondary randomized controlled trial results. BJOG. 2016 Apr;123(5):844. [Impact factor: 3.407]
  • Mukaddam A, Patil R, Jaldi A, S Chandrakala, Ghosh K, Shetty S. Paradoxical bleeding and thrombosis in a patient with afibrinogenemia and Fibrinogen Mumbai mutation. Am J Clin Pathol May 2015;143:1-3. [Pubmed indexed] [Impact factor: 3.005]
  • Patil R, Ghosh K, Shetty S. Comment: “Low-Molecular-Weight Heparin for Women With Unexplained Recurrent Pregnancy Loss” Ann Intern Med. 2015 Sep 15;163(6):483-4.[Impact factor: 17.8].
  • Patil R, Ghosh K, Vora S, Shetty S. Inherited and acquired thrombophilia in Indian women experiencing unexplained recurrent pregnancy loss.Blood Cells Mol Dis. 2015; 55:200-5. [Impact factor: 2.646].
  • Patil R, Ghosh K, Shetty S. Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice: comment.J Thromb Haemost.2015; 13:1737-8. [Impact factor: 5.55].
  • Patil R, Ghosh K, Damania K, Bansal V, Satoskar P, Darekar A, Shetty, S. Effect of anticoagulant therapy on cell-derived microparticles (MP) and pregnancy outcome in women with pregnancy loss. Br J Haematol 2015; 171:892-6. [Impact factor: 4.959]
  • Pinto P, Shelar T, Nawadkar V, Mirgal D, Mukaddam A, Nair P, Kasatkar P, Gaikwad T, Ali S, Jadli A, Patil R, Parihar A, Shanbhag S, Kulkarni B, Ghosh K, Shetty S. The Epidemiology of FVIII Inhibitors in Indian Haemophilia A Patients. Indian J Hematol Blood Transfus. 2014 Dec;30(4):356-63. [Pubmed indexed] [Impact factor: 0.234]
  • Ghosh K, Shetty S, Patil R. Is thrombophilia associated with placenta-mediated pregnancy complications? A prospective cohort study: comment. J Thromb Haemost. 2014;12(8):1377-8. [Pubmed indexed] [Impact factor: 5.55]
  • Shetty S, Patil R, Ghosh K. Role of microparticles in recurrent miscarriages and other adverse pregnancies: a review. Eur J Obstet Gynecol Reprod Biol. 2013;169(2):123-9. [Pubmed indexed] [Impact factor: 1.627]
  • Patil R, Ghosh K, Satoskar P, Shetty S. Elevated procoagulant endothelial and tissue factor expressing microparticles in women with recurrent pregnancy loss. PLoS One 2013;20:e81407. [Impact factor: 3.534]
  • Patil R, Ghosh K, Shetty S. Profibrinolytic MPs are not adequately produced to compensate their prothrombotic effect. Haematologica 2013; 98:e69. [Impact factor: 5.866]
  • Haemostasis, Thrombosis, Cell-derived microparticles, Immunology, Molecular Biology, Flow cytometry